Salmonics, a biotech startup at TechPlace in Brunswick, is taking part in a 12-month residency at Northeastern University’s Roux Institute in Portland with a goal to refine its technology and enhance ...

MISSOULA, Mont. — The University of Montana received a four-year $4 million Research Evaluation and Commercialization Hub award from the National Institutes of Health. The funding will be used to ...

* Purdue President Martin C. Jischke says the agreement with the Mann Foundation will help speed laboratory discoveries into the marketplace. (33 seconds) * Alfred Mann, chairman of the Alfred Mann ...

Dublin, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The "Centerline Biomedical Inc - Product Pipeline Analysis, 2023 Update" company profile has been added to ResearchAndMarkets.com's offering. Centerline ...

The Cornell University Biomedical Device team is developing a novel product intended to treat patients undergoing opioid withdrawal for its Spring 2024 project. The device is an addition to the team’s ...

Bringing regulated biomedical technologies (small molecules, biologics, medical devices, diagnostics and combination products) from the laboratory to the bedside is one of the more complex and ...

TAUNTON, U.K., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global manufacturer of surgical technologies and medical device components announced today the launch of its Biomedical ...

DUBLIN--(BUSINESS WIRE)--The "VisionQuest Biomedical LLC - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering. Summary VisionQuest Biomedical ...

Lifecore Biomedical has been selected by Humanetics Corporation to provide contract development and manufacturing services to support the development of BIO 300, a radioprotective agent aimed at ...

Clearside Biomedical's CMO presented drug development insights at the Edridge Green Lecture, published in Eye journal, focusing on retinal disease trials. Clearside Biomedical, Inc., a ...

The allocation of risks and benefits of publicly sponsored biomedical research is becoming increasingly skewed toward for-profit entities and against the public interest. A legitimate solution to this ...